Debatin KM - Search Results

1

Le Deist F, Hivroz C, Partiseti M, Rieux-Laucat F, Debatin KM, Choquet D, De Villartay JP, Fischer A. Le Deist F, et al. Among authors: debatin km. Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 2):S163-4. doi: 10.1016/s0090-1229(95)90072-1. Clin Immunol Immunopathol. 1995. PMID: 7554460 Review. No abstract available.

2

Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibody.

Durandy A, Le Deist F, Emile JF, Debatin K, Fischer A. Durandy A, et al. Eur J Immunol. 1997 Feb;27(2):538-43. doi: 10.1002/eji.1830270227. Eur J Immunol. 1997. PMID: 9045928

3

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP. Rieux-Laucat F, et al. Among authors: debatin km. Science. 1995 Jun 2;268(5215):1347-9. doi: 10.1126/science.7539157. Science. 1995. PMID: 7539157

4

Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.

Strauss G, Osen W, Debatin KM. Strauss G, et al. Among authors: debatin km. Clin Exp Immunol. 2002 May;128(2):255-66. doi: 10.1046/j.1365-2249.2002.01777.x. Clin Exp Immunol. 2002. PMID: 11985515 Free PMC article.

5

Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.

Scheurer J, Reisser T, Leithäuser F, Messmann JJ, Holzmann K, Debatin KM, Strauss G. Scheurer J, et al. Among authors: debatin km. Clin Exp Immunol. 2020 Dec;202(3):407-422. doi: 10.1111/cei.13496. Epub 2020 Aug 1. Clin Exp Immunol. 2020. PMID: 32681646 Free PMC article.

6

4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG.

Strauss G, Westhoff MA, Fischer-Posovszky P, Fulda S, Schanbacher M, Eckhoff SM, Stahnke K, Vahsen N, Kroemer G, Debatin KM. Strauss G, et al. Among authors: debatin km. Cell Death Differ. 2008 Feb;15(2):332-43. doi: 10.1038/sj.cdd.4402272. Epub 2007 Nov 23. Cell Death Differ. 2008. PMID: 18034189

7

In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease.

Hartmann N, Leithäuser F, Albers C, Duyster J, Möller P, Debatin KM, Strauss G. Hartmann N, et al. Among authors: debatin km. Leukemia. 2011 May;25(5):848-55. doi: 10.1038/leu.2011.16. Epub 2011 Feb 18. Leukemia. 2011. PMID: 21331071

8

Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity.

Strauss G, Osen W, Knape I, Jacobsen EM, Müller SM, Debatin KM. Strauss G, et al. Among authors: debatin km. Cell Death Differ. 2007 Mar;14(3):480-8. doi: 10.1038/sj.cdd.4402019. Epub 2006 Aug 11. Cell Death Differ. 2007. PMID: 16902496

9

Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.

Fabricius D, Breckerbohm L, Vollmer A, Queudeville M, Eckhoff SM, Fulda S, Strauss G, Debatin KM, Jahrsdörfer B, Meyer LH. Fabricius D, et al. Among authors: debatin km. Leukemia. 2011 Jul;25(7):1111-21. doi: 10.1038/leu.2011.87. Epub 2011 Apr 29. Leukemia. 2011. PMID: 21527935

10

Keuper M, Wernstedt Asterholm I, Scherer PE, Westhoff MA, Möller P, Debatin KM, Strauss G, Wabitsch M, Fischer-Posovszky P. Keuper M, et al. Among authors: debatin km. Cell Death Dis. 2013 Jan 24;4(1):e474. doi: 10.1038/cddis.2012.212. Cell Death Dis. 2013. PMID: 23348588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

529 results

Search Page